|
Name: Dr. Amol G. DikundwarAssistant Professor amol.dikundwar@niperhyd.ac.in +91 40 23074750 Extn- 2035 +91-040-23074750 (Ext. No: 2036) Citations Link |
BRIEF PROFILE 
Dr. Amol G. Dikundwar is an analytical scientist with expertise in materials characterization and pharmaceutical analysis. He earned his PhD in Chemical Sciences from the Indian Institute of Science (IISc), Bengaluru, in 2013, and brings over seven years of industrial experience in materials science engineering and analytical R&D. He has contributed to multidisciplinary drug discovery and development programmes, including process analytical technologies (PAT) and regulatory support for drug substances and drug products.
Since February 2021, Dr. Amol has been at NIPER Hyderabad, where he leads an interdisciplinary research group focused on understanding how molecular structure, solid-state properties, formulation design, and biological interactions collectively influence drug performance, quality, and therapeutic outcomes. His laboratory integrates crystallography, crystal engineering, advanced solid-state pharmaceutics, and modern analytical and bioanalytical approaches to address challenges across the pharmaceutical development continuum.
ADDRESS, ROOM NO 
Department of Pharmaceutical Analysis
Room no: 05
NIPER Hyderabad
Balanagar, Hyderabad-500037, TS, INDIA
QUALIFICATION: (REVERSE CHRONOLOGICAL ORDER)
Doctor of Philosophy (Ph.D.)
Institute: Solid state and Structural Chemistry Unit, Indian Institute of Science, Bangalore, India [2008-2013]
Dissertation: Organic Flourine in Crystal engineering: Consequences at Molecular and Supramolecular level. (Thesis advisor: Professor T. N. Guru Row; worked with Prof. G. R. Desiraju on collaborative projects)
Research areas: In situ cryocrystallography, crystal engineering and polymorphism, charge density analysis, neutron diffraction, powder diffraction
Master of Science (M.Sc.)
Institute: Department of Chemistry, RTM Nagpur University, Nagpur, India [2005-2007] (First division)
Specialization: Organic chemistry with Medicinal chemistry as optional credits
Bachelor of Science (B.Sc.)
Institute: Lokmanya Tilak Mahavidyalaya, Wani, SGB Amaravati University, Amaravati, India [2002-2005] (Distinction)
Specialization: Major Subjects: Physics, Chemistry and Mathematics
EXPERIENCE 
Assistant Professor, January 2021 - Till date at NIPER, Hyderabad, India
Principal Investigator (Apr 2018 - Jan 2021) at Analytical Research & Development, Biocon Bristol-Myers Squibb Research and Development Center, Syngene International Limited, Bangalore, India
Senior Research Investigator (Jan 2016 - Mar 2018) at Analytical Research & Development, Biocon Bristol-Myers Squibb Research and Development Center, Syngene International Limited, Bangalore, India
Research Investigator (Sep 2013 - Dec 2015) at Biopharmaceutics, Biocon Bristol-Myers Squibb Research and Development Center, Syngene International Limited, Bangalore, India 
PHD STUDENTS/MASTERS STUDENTS
| Sr. No. | Name |
|---|---|
| 1 | Rekha Sapkal |
| 2 | Shiva Gogikar |
| 3 | Siddhartha Nagamalli |
| 4 | Ramakanta Patel |
| 5 | Avvaru Jubha Jahnavi |
| 6 | P. Shivashankar |
| 7 | Sibu Sen |
| 8 | Shraddha Katarpawar |
| 9 | Rushikesh Suradkar |
| 10 | Abhishek Sharma (under co-supervision) |
| Sr. No. | Name |
|---|---|
| 1 | Chandrakanta Mohapatra |
| 2 | Irkar Vaishanvi Maddappa |
| 3 | Jagtap Yash Machindra |
| 4 | Guru Naik |
| 5 | Pappu Sarkar |
| 6 | Waghmare Mahesh Namdev |
| Sr. No. | Name |
|---|---|
| 1 | Nagesh Bhale |
| Sr. No. | Name |
|---|---|
| 1 | Pratik Pramod Deshpande |
| 2 | Pratima Kendre |
| 3 | Pallavi Jock |
| 4 | Quadri Syeda Sadaf |
| 5 | Shaikh Nadeem Nazeemsab |
| 6 | Sibu Sen |
| 7 | Yerukala Penugonda Raghvendra |
| 8 | Agade Suraj Bhaskar |
| 9 | Birajdar Ganesh Pandit |
| 10 | Daravath Sandeep |
| 11 | Gobade Ganesh Pandurang |
| 12 | Kamuni Vinathi |
| 13 | Vartika Ranjit Singh |
| 14 | Sodnar Ashok Mhatu |
| 15 | Srishti Singh |
| 16 | G. Jyothi |
| 17 | Pawan M. Kurhade |
| 18 | Soumyajit Dey |
| 19 | Onkar Sarjerao Solanke |
| 20 | Faizan Toufeeque Momin |
| 21 | Munesh Kumari |
| 22 | Sasitharan N |
| 23 | Vedang Junagade |
| 24 | Pravin Vikaram Chavan |
| 25 | Ganashree G |
| 26 | Ramadevi S |
| 27 | Tejas Dhon |
| 28 | Vishal Maurya |
AWARDS / HONOURS 
Poster prize at Applied Pharmaceutical Analysis conference (APA-India 2020) at Ahmedabad, India
“BMS Bravo Award-2018” for establishing PoC of using existing small molecule crystallography set up for protein data collection
“Excellence Award-2018” for successful in-house transition of a molecule across various stages of drug development
First position (team Soch) in case study analysis and presentation competition on “Diversity and Inclusion”, 2017
“Galaxy Award-2016” for successful completion of lead optimization for Allied Bristol-Myers Squibb Life Sciences (ABLS-02) program
“BMS Star Award-2015” for organising and conducting a short course (20 hours) ‘Polymorphism and Crystallization in Pharmaceuticals’ for fellow scientists within PD organization
“CCDC Poster Prize” in the 22nd IUCr general assembly, Madrid, Spain for the presentation of the poster entitled
“‘Organic’ Fluorine Dictates the Molecular Conformation and Packing” in August 2011
“IUCr Best Poster Award” in the ICCOSSXX, Bangalore, India for the presentation of the poster entitled “Structural Variability in the Monofluorophenylacetylenes Mediated through Interactions Involving ‘Organic’ Fluorine” in June 2011
Qualified National Eligibility Test (NET-2007, JRF) and Graduate Aptitude Test Examination (GATE-2008, percentile 98.88)
National Cadet Corps (NCC) A, B and C certificates
Member of Indian Crystallography Association and Marathi Vidhyan Parishad, Mumbai
Member of International Center for Diffraction Data (ICDD)
RESEARCH AREAS/INTEREST
The laboratory focuses on the rational design, development, and characterization of pharmaceutical solid forms to improve the physicochemical and biopharmaceutical performance of drug molecules. Research encompasses form screening and selection of polymorphs, salts, cocrystals, eutectics, hydrates, solvates, neat amorphous forms, coamorphous systems, and amorphous solid dispersions. The group investigates solid-state phase transformations, relative polymorphic stability, polyamorphism, crystallisation pathways and process development, and formulation enablement strategies to support pharmaceutical development while mitigating solid-form-related risks during manufacturing and commercialization.
Research in crystallography is directed towards understanding molecular and supramolecular organization in pharmaceutical materials using advanced structural characterization techniques. The laboratory employs single-crystal X-ray diffraction for structure elucidation, crystallographic computations, quantum chemical calculations, and experimental and theoretical charge-density analyses to investigate intermolecular interactions and structure-property relationships. Structural information is further utilized to predict physicochemical behaviour, support lead optimization, and understand molecular packing using data from the Cambridge Structural Database.
The laboratory employs a comprehensive suite of analytical techniques to characterize pharmaceutical materials and investigate their solid-state behaviour. Research includes high-resolution powder X-ray diffraction, indexing, profile fitting, Rietveld refinement, ab initio structure determination, and advanced amorphous characterization using total scattering and pair distribution function (TS-PDF) analysis. Complementary techniques such as DSC, mDSC, TGA, DVS, FTIR, Raman spectroscopy, Karl Fischer titration, optical microscopy, and particle size and morphology analysis are routinely applied to establish structure-property relationships and evaluate pharmaceutical performance.
Research focuses on developing robust pharmaceutical processes for producing stable and manufacturable drug substances and dosage forms. Major areas include crystallization process development, particle engineering, particle size optimization, crystal habit modification and morphology control, milling, process optimization, scale-up considerations, and accelerated solid-state stability studies of drug substances, intermediates, and finished pharmaceutical products.
The laboratory is involved in the development and validation of analytical and bioanalytical methods for qualitative and quantitative analysis of pharmaceuticals, complex formulation matrices, biological samples, nutraceuticals, and environmental matrices. Research activities include pharmaceutical impurity profiling, forced degradation studies, stability-indicating analytical methods, trace-level contaminant analysis, and regulatory-compliant analytical method development using HPLC, UHPLC, LC-MS/MS, LC-HRMS, GC-MS, and ICP-MS platforms.
The laboratory investigates the influence of formulation design and molecular properties on drug disposition and therapeutic performance. Research includes pharmacokinetic and pharmacodynamic evaluation, drug metabolism, drug-drug interaction studies, CYP enzyme phenotyping, in vitro-in vivo extrapolation (IVIVE), and physiologically based pharmacokinetic (PBPK) modelling to support rational pharmaceutical development and translational research.
By integrating advanced mass spectrometry with computational data analysis, the group performs targeted and untargeted metabolomics for biomarker discovery, cancer metabolomics, phytometabolomics, and systems-level investigations aimed at elucidating mechanisms of drug action, therapeutic efficacy, and precision pharmacotherapy. Such pharmacometabolomics and systems pharmacology investigations are leveraged for understanding metabolic alterations associated with drug therapy, disease progression, and therapeutic response.
The laboratory applies advanced analytical technologies to evaluate the quality, authenticity, and safety of natural products, traditional formulations, nutraceuticals, and environmental samples. Research interests include phytochemical characterization, phyto-metabolomics, network pharmacology, detection of organic and inorganic contaminants in food and nutritional supplements, heavy metal toxicity assessment and trace elemental analysis using ICP-MS, monitoring of pharmaceutical contaminants in environmental matrices, and assessment of their potential impact on human health and environment.
FELLOWSHIPS / GRANTS
Awarded Junior Research Fellowship (2008-2010) and Senior Research Fellowship (2010-2013) by Ministry of HRD, Government of India, India
Several travel grants for attending international conferences, synchrotron data collection (Elletra, Italy), neutron data collection (ANSTO, Australia).
PUBLICATIONS / BOOK CHAPTERS
PATENTS
INVITED TALKS 
| Title / activity | Invited by | Date |
|---|---|---|
| Applications of Crystallography in Pharmaceutical Sciences | Crystallography Workshop at M.S. Ramaiah Institute of Technology, Bangalore, | July 2014 |
| Detection and Quantification of Low Levels of Solid state Impurities by PXRD: A comparison with HPLC | Satellite workshop on PXRD in Pharmaceutical and Materials Industry (ICDD), 46th National Seminar on Crystallography at NIMHANS, Bangalore, India | June 2018 |
| Solid Form Screening and Selection in Pharmaceutical Development: Implications on Materials Properties and Performance | 46th National Seminar on Crystallography at NIMHANS, Bangalore, India | June 2018 |
| Quality Risk Management in Pharmaceutical Development | National Institute of Micro, Small and Medium Enterprises (NIMSME), Hyderabad | October 2021 |
| Sponsored Research-Opportunities, Approaches and Financial Gains (Panelist) | Sathguru Management Consultants in association with National Biopharma Mission, BIRAC (Venue: Hotel Mercure, Hyderabad) | April 2022 |
| TSCOST - Quality Assurance and Quality Control of Pharmaceuticals | Program coordinator, NIPER Hyderabad | July-October 2022 |
| TSCOST - Entrepreneurship Development Program | Program coordinator, NIPER Hyderabad | August 2022 |
| Overview of Analytical Capabilities with particular reference to solid state characterization and polymorph screening | Novartis, Hyderabad | September 2022 |
| 9th Annual Symposium of Federation of Indian Physiological Societies 2022 (Jury panel member for students presentations) | NIPER Hyderabad | March 2022 |
| Nanomechanics for Pharmaceutical Applications (NPA) 2023 (Session Chair) | Organizing Committee, NPA-2023 (Venue: Lemon Tree Premier Hitec City, Hyderabad) | December 2023 |
| TSCOST - Quality Assurance and Quality Control of Pharmaceuticals | Program coordinator, NIPER Hyderabad | December 2023-March 2024 |
| Renishaw Raman Pharma Connect event, Renishaw Metrology Systems Limited, Pune (Resource Person) | Renishaw Metrology Systems Limited, Pune | October 2024 |
| International Conference on “Frontiers in Physical and Chemical Science: Exploring New Horizons” (FPCS-2024), Acharya Institute of Graduate Studies, Bangalore | Acharya Institute of Graduate Studies, Bangalore | November 2024 |
| Chemistry-Innovation and Translations in Drug Discovery (CITDD-2025), NIPER Ahmedabad (Session co-chair) | NIPER Ahmedabad | February 2025 |
| Latest trends in Pharmaceutical Process & PAT Solutions | Spinco Limited, Hyderabad (Venue: Hotel The Park, Somajiguda, Hyderabad) | March 2025 |
| NDTL Annual Conference -2025 on "Anti-Doping Science: Innovations and Challenges," held at India International Centre, New Delhi (Panelist) | National Dope Testing Laboratory (NDTL), New Delhi | March 2025 |
SPONSORED PROJECTS
| Sr. No. | Title of project | Role | Funding agency | Amount (Rs. Lakhs) | Status |
|---|---|---|---|---|---|
| 1 | Solid state characterization of Pharmaceuticals (Karyashala – Workshop Under Abhyaas scheme) | PI | DST-SERB | 4.00 | Completed |
| 2 | Co-amorphous Forms for Bioavailability Enhancement of poorly Soluble Drugs: Design, Synthesis, Characterization and in-vivo studies | PI | DST-SERB | 30.42 | Completed |
| 3 | Institutional project on Trace Level Detection of Doping Agents in Nutritional Supplements | PI | Department of Sports, Ministry of Youth Affairs and Sports, Government of India | 631.20 | Ongoing |
| 4 | Institutional project on Surveillance on Food for Special Dietary Use (FSDU) for Sports Persons | PI | FSSAI | 76.70 | Ongoing |
| 5 | Evaluation of Drug Interaction Potential of Majooen-e-Dabeed-ul-Ward with Atorvastatin and Ours-e-Ziabetus Khaas with Metformin | Co-PI | CCRUM | 43.66 | Ongoing |
| 6 | Pharmacokinetic interaction of Majoon Najah with combination of (Carbidopa+Levodopa) and neuroprotective potential of Majoon Najah in haloperidol disease. | Co-PI | CCRUM | 13.36 | Ongoing |
| Sr. No. | Title of project | Role | Funding agency | Amount (Rs. Lakhs) | Status |
|---|---|---|---|---|---|
| 1 | Solid state characterization of modified solid-state forms of API | PI | Bristol Myers Squibb, USA | 7.44 | Completed |
| 2 | Tracing a root cause for the formation of N-methyl impurity in Norfloxacin | Co-PI | Nakoda Chemicals Limited, Hyderabad | 1.80 | Completed |
| 3 | Quantification of polymorphic impurity in Famotidine API (Consultancy Project) | PI | Nakoda Chemicals Limited, Hyderabad | 0.70 | Completed |
| 5 | Formulation Development and Analytical Characterization of N-Acetyl Cysteine based antibiotic formulations as intrauterine dosage form for veterinary use | PI | Heka Pharmaceuticals Private Limited | 4.13 | Completed |
| 6 | Customized analytical support to projects under institutes analytical services mode (Quantitative phase analysis by PXRD; Core size determination of complex metal based formulations by PXRD; Determination of collapse temperature and freezing point temperature for lyophilized dosage forms by Cryo-DSC/mDSC; Sameness study for complex generics by comparison with RLD by PXRD, FTIR and DSC; Absolute structure determination by 2D-NMR and Single Crystal XRD; Correlation of dissolution with phase analysis by Powder XRD; residual content by GC; Elemental impurities quantification by ICP-MS; Method development and validation for nitrosamine impurities using LC-MS/GC-MS; Elemental composition by HRMS, etc.) | PI | Nakoda Chemicals Limited; Orbicular Pharmacutical Technologies Pvt. Ltd.; DifGen Pharmaceuticals Pvt. Ltd.; Neuland Pharma; Metrochem API; Enal Drugs Pvt. Ltd.; Aurore Life Sciences; Saptagir Camphor Private Limited; Synthochem Pvt. Ltd.; SETV ASRV Pharma; etc. | - | Completed/ Ongoing |
Laboratory facilities developed for research / teaching. 
ADDITIONAL RESPONSIBILITIES 